{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T02:03:15Z","timestamp":1772676195716,"version":"3.50.1"},"reference-count":34,"publisher":"American Society for Microbiology","issue":"4","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2007,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Antibody avidity, the strength of the multivalent interaction between antibodies and their antigens, is an important characteristic of protective immune responses. We have developed an inhibition enzyme-linked immunosorbent assay (ELISA) to measure antibody avidity for the capsular polysaccharide (PS) of<jats:italic>Neisseria meningitidis<\/jats:italic>group C (MnC) and determined the avidity constants (<jats:italic>K<jats:sub>D<\/jats:sub><\/jats:italic>s) for 100 sera from children immunized with an MnC PS conjugate vaccine. The avidity constants were compared to the avidity indices (AI) obtained for the same sera using a chaotropic ELISA protocol. After the primary immunization series, the geometric mean (GM)<jats:italic>K<jats:sub>D<\/jats:sub><\/jats:italic>was 674 nM and did not change in the months following immunization. However, the GM avidity did increase after the booster dose (GM<jats:italic>K<jats:sub>D<\/jats:sub><\/jats:italic>, 414 nM 1 month after booster immunization). In contrast, the GM AI increased from an initial value of 118 after the primary immunization series to 147 6 months after the completion of the primary immunization series and then further increased to 178 after booster immunization. At the individual subject level, the avidity constant and AI correlated after the primary immunization series and after booster immunization but not prior to boosting. This work suggests that the AI, as measured by the chaotropic ELISA, in contrast to the<jats:italic>K<jats:sub>D<\/jats:sub><\/jats:italic>, reflects changes that render antibody populations less susceptible to disruption by chaotropic agents without directly affecting the strength of the binding interactions.<\/jats:p>","DOI":"10.1128\/cvi.00241-06","type":"journal-article","created":{"date-parts":[[2007,2,8]],"date-time":"2007-02-08T01:29:01Z","timestamp":1170898141000},"page":"397-403","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":15,"title":["Avidity of the Immunoglobulin G Response to a<i>Neisseria meningitidis<\/i>Group C Polysaccharide Conjugate Vaccine as Measured by Inhibition and Chaotropic Enzyme-Linked Immunosorbent Assays"],"prefix":"10.1128","volume":"14","author":[{"given":"Shannon L.","family":"Harris","sequence":"first","affiliation":[{"name":"Wyeth Vaccines Research, Pearl River, New York"},{"name":"Immunobiology Unit, Institute of Child Health, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"How","family":"Tsao","sequence":"additional","affiliation":[{"name":"Wyeth Vaccines Research, Pearl River, New York"},{"name":"Immunobiology Unit, Institute of Child Health, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsey","family":"Ashton","sequence":"additional","affiliation":[{"name":"Wyeth Vaccines Research, Pearl River, New York"},{"name":"Immunobiology Unit, Institute of Child Health, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Goldblatt","sequence":"additional","affiliation":[{"name":"Wyeth Vaccines Research, Pearl River, New York"},{"name":"Immunobiology Unit, Institute of Child Health, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Fernsten","sequence":"additional","affiliation":[{"name":"Wyeth Vaccines Research, Pearl River, New York"},{"name":"Immunobiology Unit, Institute of Child Health, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1086\/515298","volume":"177","year":"1998","unstructured":"Anttila, M., J. Eskola, H. Ahman, and H. Kayhty. 1998. Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines. J. Infect. Dis.177:1614-1621.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_1_3_2","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/S0264-410X(98)00458-7","volume":"17","year":"1999","unstructured":"Anttila, M., J. Eskola, H. Ahman, and H. Kayhty. 1999. Differences in the avidity of antibodies evoked by four different pneumococcal conjugate vaccines in early childhood. Vaccine17:1970-1977.","journal-title":"Vaccine"},{"key":"e_1_3_1_4_2","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1046\/j.1365-2249.1999.01077.x","volume":"118","year":"1999","unstructured":"Anttila, M., M. Voutilainen, V. Jantti, J. Eskola, and H. Kayhty. 1999. Contribution of serotype-specific IgG concentration, IgG subclasses and relative antibody avidity to opsonophagocytic activity against Streptococcus pneumoniae. Clin. Exp. Immunol.118:402-407.","journal-title":"Clin. Exp. Immunol."},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.3.1568-1573.2001"},{"key":"e_1_3_1_6_2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1086\/322024","volume":"184","year":"2001","unstructured":"Borrow, R., D. Goldblatt, N. Andrews, P. Richmond, J. Southern, and E. Miller. 2001. Influence of prior meningococcal C polysaccharide vaccination on the response and generation of memory after meningococcal C conjugate vaccination in young children. J. Infect. Dis.184:377-380.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_1_7_2","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1086\/344324","volume":"186","year":"2002","unstructured":"Borrow, R., D. Goldblatt, N. Andrews, J. Southern, L. Ashton, S. Deane, R. Morris, K. Cartwright, and E. Miller. 2002. Antibody persistence and immunological memory at age 4 years after meningococcal group C conjugate vaccination in children in the United kingdom. J. Infect. Dis.186:1353-1357.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.10.5549-5555.2003"},{"key":"e_1_3_1_9_2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.2517-6161.1964.tb00553.x","volume":"26","year":"1964","unstructured":"Box, G. E. P., and D. R. Cox. 1964. An analysis of transformations. J. R. Stat. Soc. B26:211-243.","journal-title":"J. R. Stat. Soc. B"},{"key":"e_1_3_1_10_2","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0076-6879(94)47022-7","volume":"247","year":"1994","unstructured":"Bundle, D. R., and B. W. Sigurskjold. 1994. Determination of accurate thermodynamics of binding by titration microcalorimetry. Methods Enzymol.247:288-305.","journal-title":"Methods Enzymol."},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.9.4946-4954.2002"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.1.369-377.2005"},{"key":"e_1_3_1_13_2","doi-asserted-by":"crossref","first-page":"6737","DOI":"10.1021\/bi00020a019","volume":"34","year":"1995","unstructured":"Evans, S. V., B. W. Sigurskjold, H. J. Jennings, J. R. Brisson, R. To, W. C. Tse, E. Altman, M. Frosch, C. Weisgerber, H. D. Kratzin, et al. 1995. Evidence for the extended helical nature of polysaccharide epitopes. The 2.8 A resolution structure and thermodynamics of ligand binding of an antigen binding fragment specific for alpha-(2\u21928)-polysialic acid. Biochemistry34:6737-6744.","journal-title":"Biochemistry"},{"key":"e_1_3_1_14_2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0022-1759(85)90044-4","volume":"77","year":"1985","unstructured":"Friguet, B., A. F. Chaffotte, L. Djavadi-Ohaniance, and M. E. Goldberg. 1985. Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay. J. Immunol. Methods77:305-319.","journal-title":"J. Immunol. Methods"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.1.239-246.2000"},{"key":"e_1_3_1_16_2","first-page":"1136","volume":"10","year":"2003","unstructured":"Giardina, P. C., R. E. Evans, D. J. Sikkema, D. Madore, and S. W. Hildreth. 2003. Effect of antigen coating conditions on enzyme-linked immunosorbent assay for detection of immunoglobulin G antibody to Neisseria meningitidis serogroup Y and W135 capsular polysaccharide antigens in serum. Clin. Diagn. Lab. Immunol.10:1136-1140.","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"e_1_3_1_17_2","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1128\/CDLI.12.5.586-592.2005","volume":"12","year":"2005","unstructured":"Giardina, P. C., E. Longworth, R. E. Evans-Johnson, M. L. Bessette, H. Zhang, R. Borrow, D. Madore, and P. Fernsten. 2005. Analysis of human serum immunoglobulin G against O-acetyl-positive and O-acetyl-negative serogroup W135 meningococcal capsular polysaccharide. Clin. Diagn. Lab. Immunol.12:586-592.","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"e_1_3_1_18_2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1086\/338474","volume":"185","year":"2002","unstructured":"Goldblatt, D., R. Borrow, and E. Miller. 2002. Natural and vaccine-induced immunity and immunologic memory to Neisseria meningitidis serogroup C in young adults. J. Infect. Dis.185:397-400.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_1_19_2","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/01.inf.0000129686.12470.e6","volume":"23","year":"2004","unstructured":"Granoff, D. M., and S. L. Harris. 2004. Protective activity of group C anticapsular antibodies elicited in two-year-olds by an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid conjugate vaccine. Pediatr. Infect. Dis. J.23:490-497.","journal-title":"Pediatr. Infect. Dis. J."},{"key":"e_1_3_1_20_2","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1016\/j.vaccine.2005.03.031","volume":"23","year":"2005","unstructured":"Granoff, D. M., A. Morgan, and J. A. Welsch. 2005. Immunogenicity of an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid conjugate vaccine in 2-year old children. Vaccine23:4307-4314.","journal-title":"Vaccine"},{"key":"e_1_3_1_21_2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0022-1759(93)90096-P","volume":"157","year":"1993","unstructured":"Gray, B. M., and D. R. Shaw. 1993. Artifacts with the thiocyanate elution method for estimating relative antibody avidity. J Immunol. Methods157:269-271.","journal-title":"J Immunol. Methods"},{"key":"e_1_3_1_22_2","first-page":"275","volume":"15","year":"1993","unstructured":"Greenspan, N. S., and L. J. Cooper. 1993. Cooperative binding by mouse IgG3 antibodies: implications for functional affinity, effector function, and isotype restriction. Springer Semin. Immunopathol.15:275-291.","journal-title":"Springer Semin. Immunopathol."},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.1.275-286.2003"},{"key":"e_1_3_1_24_2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0022-1759(88)90196-2","volume":"106","year":"1988","unstructured":"Macdonald, R. A., C. S. Hosking, and C. L. Jones. 1988. The measurement of relative antibody affinity by ELISA using thiocyanate elution. J. Immunol. Methods106:191-194.","journal-title":"J. Immunol. Methods"},{"key":"e_1_3_1_25_2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0022-1759(97)00059-8","volume":"205","year":"1997","unstructured":"McCloskey, N., M. W. Turner, and T. D. Goldblatt. 1997. Correlation between the avidity of mouse-human chimeric IgG subclass monoclonal antibodies measured by solid-phase elution ELISA and biospecific interaction analysis (BIA). J. Immunol. Methods205:67-72.","journal-title":"J. Immunol. Methods"},{"key":"e_1_3_1_26_2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0022-1759(90)90037-V","volume":"132","year":"1990","unstructured":"Meikle, P. J., N. M. Young, and D. R. Bundle. 1990. O-antigen biotin conjugates. Preparation and use in direct competitive enzyme immunoassays. J. Immunol. Methods132:255-261.","journal-title":"J. Immunol. Methods"},{"key":"e_1_3_1_27_2","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1086\/314989","volume":"180","year":"1999","unstructured":"Pichichero, M. E., T. Voloshen, D. Zajac, and S. Passador. 1999. Avidity maturation of antibody to Haemophilus influenzae type b (Hib) after immunization with diphtheria-tetanus-acellular pertussis-Hib-hepatitis B combined vaccine in infants. J. Infect. Dis.180:1390-1393.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_1_28_2","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1086\/317646","volume":"183","year":"2001","unstructured":"Richmond, P., R. Borrow, D. Goldblatt, J. Findlow, S. Martin, R. Morris, K. Cartwright, and E. Miller. 2001. Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers. J. Infect. Dis.183:160-163.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_1_29_2","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0264-410X(99)00276-5","volume":"18","year":"1999","unstructured":"Richmond, P., D. Goldblatt, P. C. Fusco, J. D. Fusco, I. Heron, S. Clark, R. Borrow, and F. Michon. 1999. Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults. Vaccine18:641-646.","journal-title":"Vaccine"},{"key":"e_1_3_1_30_2","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1128\/CDLI.12.9.1029-1035.2005","volume":"12","year":"2005","unstructured":"Romero-Steiner, S., P. F. Holder, P. Gomez de Leon, W. Spear, T. W. Hennessy, and G. M. Carlone. 2005. Avidity determinations for Haemophilus influenzae Type b anti-polyribosylribitol phosphate antibodies. Clin. Diagn. Lab. Immunol.12:1029-1035.","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"e_1_3_1_31_2","unstructured":"Sigurdardottir S. T. K. Davidsdottir V. A. Arason O. Jonsdottir and F. Laudat. 2005. Safety and immunogenicity of CRM197 conjugated 9-valent pneumococcal and meningococcal C combination vaccine (9vPnCMnCC) administrated in two or three primary doses in infancy abstr. 288. Twenty-Third Annual Meeting of the European Society for Paediatric Infectious Diseases-ESPID Valencia Spain 18 to 20 May 2005."},{"key":"e_1_3_1_32_2","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1128\/CDLI.11.6.1100-1104.2004","volume":"11","year":"2004","unstructured":"Southern, J., S. Deane, L. Ashton, R. Borrow, D. Goldblatt, N. Andrews, P. Balmer, R. Morris, J. S. Kroll, and E. Miller. 2004. Effects of prior polysaccharide vaccination on magnitude, duration, and quality of immune responses to and safety profile of a meningococcal serogroup C tetanus toxoid conjugate vaccination in adults. Clin. Diagn. Lab. Immunol.11:1100-1104.","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"e_1_3_1_33_2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0022-1759(90)90401-G","volume":"132","year":"1990","unstructured":"Vorberg, E., and D. R. Bundle. 1990. Carbohydrate-enzyme conjugates for competitive EIA. J. Immunol. Methods132:81-89.","journal-title":"J. Immunol. Methods"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(89)90213-3"},{"key":"e_1_3_1_35_2","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1086\/323648","volume":"184","year":"2001","unstructured":"Wuorimaa, T., R. Dagan, M. Vakevainen, F. Bailleux, R. Haikala, M. Yaich, J. Eskola, and H. Kayhty. 2001. Avidity and subclasses of IgG after immunization of infants with an 11-valent pneumococcal conjugate vaccine with or without aluminum adjuvant. J. Infect. Dis.184:1211-1215.","journal-title":"J. Infect. Dis."}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00241-06","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00241-06","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T17:12:39Z","timestamp":1736788359000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00241-06"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["10.1128\/CVI.00241-06"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00241-06","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4]]},"assertion":[{"value":"2006-06-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2007-01-31","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}